RALLYBIO CORPORATION APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
RALLYBIO CORPORATION (RLYB) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $1.05 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2021-11-10
- RALLYBIO CORPORATION apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2021-09-30 was $1.05M, a 283.64% increase year-over-year.
- RALLYBIO CORPORATION apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2020-09-30 was $275.00K.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month |
|---|---|---|
| 2021-09-30 | $1.05M 10-Q · filed 2021-11-10 | $2.12M 10-Q · filed 2021-11-10 |
| 2020-09-30 | $275.00K 10-Q · filed 2021-11-10 | $475.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |